levodopa has been researched along with Cocaine Abuse in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (38.46) | 29.6817 |
| 2010's | 8 (61.54) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grabowski, J; Green, CE; Lindsay, JA; Moeller, FG; Rathnayaka, NS; Schmitz, JM; Stotts, AL | 1 |
| Green, CE; Kosten, TR; Lane, SD; Liu, S; Moeller, FG; Nielsen, DA; Schmitz, JM | 1 |
| Amato, L; Davoli, M; De Crescenzo, F; Minozzi, S; Pani, PP; Solimini, R; Vecchi, S; Zuccaro, P | 1 |
| Bedi, G; Bisaga, A; Foltin, RW; Nunes, EV; Shiffrin, L; Vadhan, NP | 1 |
| Green, CE; Lane, SD; Schmitz, JM; Suchting, R; Vincent, JN; Wardle, MC | 1 |
| Green, CE; Lindsay, JA; Moeller, FG; Schmitz, JM; Stotts, AL | 1 |
| Weinshenker, D | 1 |
| Amato, L; Davoli, M; Minozzi, S; Pani, PP; Solimini, R; Vecchi, S; Zuccaro, P | 1 |
| Ling, W; Majewska, MD; Montgomery, MA; Rawson, RA; Reiber, C; Shoptaw, S; Watson, DW | 1 |
| Benkelfat, C; Casey, KF; Delaney, JS; Kolivakis, T; Leyton, M | 1 |
| Grabowski, J; Moeller, FG; Mooney, ME; Schmitz, JM | 1 |
| Grabowski, J; Green, C; Moeller, FG; Mooney, ME; Schmitz, JM; Stotts, AL | 1 |
| Avison, MJ; Berger, JR; Maragos, WF; Nath, A; Schmitt, FA | 1 |
2 review(s) available for levodopa and Cocaine Abuse
| Article | Year |
|---|---|
Dopamine agonists for the treatment of cocaine dependence.
Topics: Amantadine; Antidepressive Agents; Bromocriptine; Cocaine-Related Disorders; Depression; Dopamine Agonists; Humans; Levodopa; Randomized Controlled Trials as Topic; Selection Bias | 2015 |
Dopamine agonists for the treatment of cocaine dependence.
Topics: Amantadine; Bromocriptine; Cocaine-Related Disorders; Depression; Dopamine Agonists; Humans; Levodopa; Randomized Controlled Trials as Topic | 2011 |
8 trial(s) available for levodopa and Cocaine Abuse
| Article | Year |
|---|---|
A two-phased screening paradigm for evaluating candidate medications for cocaine cessation or relapse prevention: modafinil, levodopa-carbidopa, naltrexone.
Topics: Adolescent; Adult; Benzhydryl Compounds; Carbidopa; Central Nervous System Stimulants; Cocaine-Related Disorders; Cognitive Behavioral Therapy; Data Interpretation, Statistical; Diagnostic and Statistical Manual of Mental Disorders; Dopamine Agents; Female; Humans; Levodopa; Male; Middle Aged; Modafinil; Motivational Interviewing; Naltrexone; Narcotic Antagonists; Neuropsychological Tests; Patient Compliance; Secondary Prevention; Treatment Outcome; Young Adult | 2014 |
The influence of dopamine β-hydroxylase gene polymorphism rs1611115 on levodopa/carbidopa treatment for cocaine dependence: a preliminary study.
Topics: Adult; Carbidopa; Cocaine-Related Disorders; Dopamine beta-Hydroxylase; Double-Blind Method; Female; Genotype; Humans; Levodopa; Male; Middle Aged; Odds Ratio; Pharmacogenetics; Polymorphism, Genetic; Treatment Outcome | 2014 |
Anhedonia Is Associated with Poorer Outcomes in Contingency Management for Cocaine Use Disorder.
Topics: Adult; Anhedonia; Behavior Therapy; Cocaine-Related Disorders; Cognitive Behavioral Therapy; Combined Modality Therapy; Dopamine Agents; Double-Blind Method; Female; Humans; Individuality; Levodopa; Male; Middle Aged; Outcome Assessment, Health Care; Reward | 2017 |
Contingency management and levodopa-carbidopa for cocaine treatment: a comparison of three behavioral targets.
Topics: Adult; Behavior Therapy; Carbidopa; Cocaine; Cocaine-Related Disorders; Dopamine Agents; Female; Humans; Levodopa; Male; Medication Adherence; Middle Aged; Proportional Hazards Models; Reinforcement, Psychology; Treatment Outcome | 2010 |
Randomized controlled pilot trial of cabergoline, hydergine and levodopa/carbidopa: Los Angeles Cocaine Rapid Efficacy Screening Trial (CREST).
Topics: Adult; Cabergoline; Carbidopa; Cocaine-Related Disorders; Dopamine Agents; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Pilot Projects | 2005 |
Cocaine craving, euphoria, and self-administration: a preliminary study of the effect of catecholamine precursor depletion.
Topics: Adult; Catecholamines; Circadian Rhythm; Cocaine; Cocaine-Related Disorders; Diet, Protein-Restricted; Dopamine Agents; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Euphoria; Humans; Levodopa; Male; Phenylalanine; Self Administration; Time Factors; Tyrosine | 2005 |
Safety, tolerability and efficacy of levodopa-carbidopa treatment for cocaine dependence: two double-blind, randomized, clinical trials.
Topics: Adult; Alcoholism; Carbidopa; Cocaine-Related Disorders; Dopamine; Double-Blind Method; Female; Humans; Levodopa; Male; Marijuana Abuse; Patient Compliance; Placebos; Safety; Socioeconomic Factors | 2007 |
Levodopa pharmacotherapy for cocaine dependence: choosing the optimal behavioral therapy platform.
Topics: Adult; Cocaine-Related Disorders; Cognitive Behavioral Therapy; Combined Modality Therapy; Diagnostic and Statistical Manual of Mental Disorders; Dopamine Agonists; Double-Blind Method; Female; Humans; Levodopa; Male; Patient Acceptance of Health Care; Patient Compliance; Retention, Psychology; Severity of Illness Index | 2008 |
3 other study(ies) available for levodopa and Cocaine Abuse
| Article | Year |
|---|---|
Effects of levodopa-carbidopa-entacapone and smoked cocaine on facial affect recognition in cocaine smokers.
Topics: Adult; Carbidopa; Catechols; Cocaine; Cocaine-Related Disorders; Drug Interactions; Face; Female; Humans; Levodopa; Male; Middle Aged; Nitriles; Smoke; Young Adult | 2016 |
Cocaine sobers up.
Topics: Aldehyde Dehydrogenase; Aldehyde Dehydrogenase, Mitochondrial; Animals; Cocaine-Related Disorders; Disulfiram; Dopamine; Humans; Levodopa; Mitochondrial Proteins; Norepinephrine; Rats; Recurrence; Self Administration; Temperance | 2010 |
Acceleration of HIV dementia with methamphetamine and cocaine.
Topics: Adult; AIDS Dementia Complex; Amphetamine-Related Disorders; Antiretroviral Therapy, Highly Active; Blood-Brain Barrier; Brain; Cholinergic Antagonists; Cocaine-Related Disorders; Disease Progression; Humans; Levodopa; Magnetic Resonance Imaging; Male; Methamphetamine; Movement Disorders | 2001 |